BOPO - BioPower Operations Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
11/29/2015
Total Revenue
444
13
Cost of Revenue
-
0
Gross Profit
44
13
Operating Expenses
Research Development
-
-
Selling General and Administrative
2,060
1,960
Total Operating Expenses
2,070
1,969
Operating Income or Loss
-2,026
-1,955
Interest Expense
382
241
Total Other Income/Expenses Net
30
-15
Income Before Tax
-2,377
-2,211
Income Tax Expense
-
-
Income from Continuing Operations
-2,377
-2,211
Net Income
-2,377
-2,211
Net Income available to common shareholders
-2,377
-2,211
Reported EPS
Basic
-
-0.05
Diluted
-
-0.05
Weighted average shares outstanding
Basic
-
41,723
Diluted
-
41,723
EBITDA
-
-1,961